MINICUCCI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 7.236
AS - Asia 672
NA - Nord America 263
SA - Sud America 53
OC - Oceania 14
AF - Africa 10
Totale 8.248
Nazione #
IT - Italia 7.126
SG - Singapore 304
US - Stati Uniti d'America 248
CN - Cina 162
VN - Vietnam 92
FR - Francia 49
BR - Brasile 38
ID - Indonesia 21
HK - Hong Kong 19
TH - Thailandia 17
AU - Australia 14
JP - Giappone 14
MY - Malesia 14
CH - Svizzera 12
DE - Germania 11
GB - Regno Unito 11
FI - Finlandia 10
PH - Filippine 7
AR - Argentina 6
CA - Canada 6
IN - India 5
PK - Pakistan 5
MX - Messico 4
RU - Federazione Russa 3
SA - Arabia Saudita 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
IE - Irlanda 2
IQ - Iraq 2
MA - Marocco 2
NL - Olanda 2
PL - Polonia 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 8.248
Città #
Genova 4.300
Genoa 1.568
Rapallo 727
Vado Ligure 497
Singapore 138
San Jose 107
Lauterbourg 46
Ashburn 28
Ho Chi Minh City 27
Bordighera 24
Hanoi 22
New York 22
Hong Kong 19
Bangkok 17
Santa Clara 17
Jakarta 16
Beijing 14
Tokyo 13
Kuala Selangor 12
Zurich 12
Helsinki 10
Frankfurt am Main 9
Council Bluffs 8
Tianjin 8
Manila 7
City of London 5
Chicago 4
Haiphong 4
Da Nang 3
Guangzhou 3
Melbourne 3
Mexico City 3
Orem 3
São Paulo 3
Bekasi 2
Bắc Ninh 2
Cape Town 2
Cardiff 2
Chennai 2
Des Moines 2
Dublin 2
Houston 2
Jeddah 2
Kuala Lumpur 2
Los Angeles 2
Macapá 2
Montreal 2
Phủ Lý 2
Salvador 2
San José 2
Thái Bình 2
Toronto 2
Agadir 1
Amsterdam 1
Aquidauana 1
Astana 1
Asunción 1
Aurangabad 1
Baku 1
Bauru 1
Belgrade 1
Bhopal 1
Biên Hòa 1
Blida 1
Boston 1
Boulogne Sur Mer 1
Brasília 1
Bình Dương 1
Bến Tre 1
Cagliari 1
Calgary 1
Campo Grande 1
Can Tho 1
Capim Branco 1
Centre de Flacq 1
Chelyabinsk 1
Chuzhou 1
Cosmópolis 1
Cruz Alta 1
Cruz das Almas 1
Curitiba 1
Dallas 1
Dearborn 1
Denver 1
Fortaleza 1
Go Vap 1
Gravataí 1
Gravatá 1
Guayaquil 1
Gujranwala 1
Hamad Town 1
Islamabad 1
Jacareí 1
Jaguarão 1
Jequié 1
João Pessoa 1
Karachi 1
Kazan' 1
Khobar 1
Lagoa Santa 1
Totale 7.783
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 241
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 220
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 195
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients Clin Chem Lab Med. 2011 Jan;49(1):49-54. 192
Pathological role of the calpain/calpastatin system in cystic fibrosis 176
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 174
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 170
Diabetes mellitus after kidney transplantation in pediatric recipients 169
Caregiver burden and vocational participation among parents of adolescents with CF 168
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 165
Discharge report accuracy 163
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 163
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 162
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 161
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 158
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 158
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 156
Home nebulizer use and bacterial colonization in cystic fibrosis. 156
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 153
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 152
Validation of a predictive survival model in Italian patients with cystic fibrosis 147
Alta incidenza di diabete di tipo 1 in Liguria nel periodo 1989-1998 145
Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience. 144
Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR 143
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 140
Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis 137
N1303K MUTATION AND DIABETES MELLITUS IN CYSTIC FIBROSIS. 136
Beclometasone dipropionato per aerosol versus budesonide per turbohaler nella broncopneumopatia della fibrosi cistica. 134
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 134
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 132
Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. 129
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 127
Oxidative stress and antioxidant therapy in cystic fibrosis. 127
Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. 125
Cystic Fibrosis - Related diabetes mellitus 122
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 119
Oral hypoglycemic agents in Cystic Fibrosis related diabetes (CFRD) 118
Identification of novel WFS1 mutations in Italian children with Wolfram Syndrome 117
Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) 116
Emergenze diabetologiche: chetoacidosi diabetica 115
Identificazione di neonati a rischio genetico di diabete tipo 1 (DM1) da avviare a prevenzione primaria (studio PREVEFIN) - Dati preliminari 113
Liver disease as risk factor for cystic fibrosis-related diabetes development 112
Elevata incidenza del diabete mellito di tipo 1 in Liguria dal 1989 al 1998 109
Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. 107
When should hyperglycemia be treated in cystic fibrosis? 107
Terapia cortisteroidea inalatoria nella broncopneumopatia della fibrosi cistica: confronto tra beclometasone dipropionato per aerosol e budesonide per turbohaler. 101
Programmi svolti dalla II Clinica Pediatrica. 101
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. 99
Marker immunologici di diabete di tipo 1 in fibrosi cistica. 96
Ruolo di alcaligenes xylodoxidans nella broncopneumopatia cronica in fibrosi cistica. 95
Nuove mutazioni del gene della wolframina in tre casi pediatrici 95
Ursodeoxycholic Acid for Liver Disease Associated with Cystic Fibrosis: A Double-Rlind Multifiter Trial 95
Prima descrizione italiana di una nuova mutazione nel gene HNF-1beta (MODY 5) 90
The adolescent with type 1 diabetes mellitus. 88
The use of ofloxacin in cystic fibrosis patients. 86
Screening for type 1 diabetes genetic rIsk in newborns of continental Italy. Primary prevention (Prevefin Italy) - preliminary data 86
Study of efficacy of piperacillin in the treatment of severe infections of the child and of the young adult 85
”Punteggi di valutazione clinica nella Fibrosi Cistica”. 84
Il Diabete in Fibrosi cistica 83
Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). 80
The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis. 79
Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate 76
Indagini per le funzioni epatobiliari 74
MODY e diabete non autoimmune. 70
Totale 8.270
Categoria #
all - tutte 23.779
article - articoli 16.693
book - libri 0
conference - conferenze 5.972
curatela - curatele 0
other - altro 250
patent - brevetti 0
selected - selezionate 0
volume - volumi 864
Totale 47.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 30 25 44
2021/2022729 9 49 55 104 20 43 56 195 18 66 21 93
2022/2023862 76 63 11 136 118 177 0 55 141 9 73 3
2023/2024427 22 51 4 52 38 114 4 33 18 8 26 57
2024/20251.100 65 116 36 83 93 127 75 180 35 42 111 137
2025/20261.559 252 38 57 94 231 195 344 78 153 117 0 0
Totale 8.270